WO2017086653A1 - Oral composition and method for preparing same - Google Patents

Oral composition and method for preparing same Download PDF

Info

Publication number
WO2017086653A1
WO2017086653A1 PCT/KR2016/012858 KR2016012858W WO2017086653A1 WO 2017086653 A1 WO2017086653 A1 WO 2017086653A1 KR 2016012858 W KR2016012858 W KR 2016012858W WO 2017086653 A1 WO2017086653 A1 WO 2017086653A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
oral composition
oil
extract
natural product
Prior art date
Application number
PCT/KR2016/012858
Other languages
French (fr)
Korean (ko)
Inventor
문형주
Original Assignee
케이덴티 주식회사
문형주
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 케이덴티 주식회사, 문형주 filed Critical 케이덴티 주식회사
Publication of WO2017086653A1 publication Critical patent/WO2017086653A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Definitions

  • the present invention relates to a composition for oral cavity and a method for producing the same.
  • Oral bacteria form plaques, which are formed throughout the teeth, especially those between the gums and the teeth that are not easily removed by conventional brushing, but also calcified and turn into tartar causing dental caries and gum disease. Cause. These oral bacteria are surrounded by fat or lipid membranes.
  • oil pooling was introduced in Ayurveda, a traditional Indian medicine book, and is a natural goggle solution for removing oral bacteria, and it is a principle of releasing toxins in the body by adsorbing oral bacteria in oil.
  • Oil pooling is usually done by putting coconut oil or olive oil in a spoonful of mouth and gargle for about 20 minutes.
  • the present invention is a natural product, including the parenthesis, gyunyanghyang, chajeon, Tobokyeong, cornus and salt; And oral compositions containing vegetable oils.
  • the present invention is a natural product, including the parenthesis, gyunyanghyang, chajeon, Tobokyeong, cornus and salt; And to provide a method for preventing caries and gum disease improvement and prevention comprising administering an oral composition containing a vegetable oil.
  • the present invention is a natural product, including a balsamin, competition fragrances, chajeonja, bokbokyeong, cornus and salt for the prevention of tooth decay and gum disease improvement and production of a preventive agent; And oral compositions containing vegetable oils.
  • natural products including gugizin, convention fragrance, chajeon, Tobokyeong, cornus and salt; And oral compositions containing vegetable oils.
  • the natural product is 30 to 60% by weight of the guru; 10 to 40% by weight of the fragrance; 5-15% by weight of electrons; Tobok age 1-10 wt%; It may include 5-15% by weight of cornus oil and 5-15% by weight of salt.
  • the natural product may be extracted, fermented or extracted and fermented.
  • the extraction is performed by a solvent comprising at least one selected from the group consisting of water, anhydrous or hydrous lower alcohols of 1-4 carbon atoms, lower ketones of 1-4 carbon atoms, lower esters of 1-4 carbon atoms, chloroform and mixtures thereof. Can be done.
  • the vegetable oil may include castor oil and nim oil.
  • the weight ratio of the castor oil and the nim oil may be 1: 1 to 5: 1.
  • the oral composition may contain 70 parts by weight to 90 parts by weight of the natural product and 10 parts by weight to 30 parts by weight of the vegetable oil.
  • the oral composition may be for inhibiting one or more oral bacteria selected from the group consisting of Streptococcus mutans, Porphyromonas Gingivalis, and Streptococcus Gordonii.
  • the oral composition may be formulated in the form of a powder, granules, tablets, capsules, creams, transparent gels or translucent gels.
  • Extraction in step (a) may be performed for 60 to 70 minutes at 80 °C to 90 °C.
  • the vegetable oil in step (b) may include castor oil and nim oil.
  • Oral compositions containing natural and vegetable oils according to the present invention are excellent in inhibiting both Streptococcus mutans, Porphyromonas Gingivalis and Streptococcus Gordonii, In addition to excellent caries prevention and gum disease prevention and prevention efficacy, oral bacteria can penetrate blood vessels and prevent heart disease.
  • Example 1 is a photograph comparing the degree of gum inflammation in vivo (b) in vivo after (a) and steadily using for about 30 days three times a day before using the health supplement toothpaste of the oral composition prepared in Example 1.
  • the present inventors prepared a composition for oral cavity containing specific natural products and vegetable oils in order to maximize the oil pooling effect while minimizing side effects, and studied caries prevention and gum disease improvement and prevention efficacy.
  • the present invention is a natural product, including the parenthesis, gyunyanghyang, chajeon, Tobokyeong, cornus and salt; And oral compositions containing vegetable oils.
  • the oral composition according to the present invention contains a natural product and a vegetable oil, in order to maximize the oil pooling effect, by adding a natural product having a negative energy form to the vegetable oil, having a positive energy form Oral bacteria can be strongly adsorbed like magnets to release toxins from the body.
  • the oral composition according to the present invention contains a natural product including a parenthesis, gyunhyang fragrance, chacha, Tobokyeong, cornus and salt, wherein the natural product is 30 to 60% by weight of the parenthesis; 10 to 40% by weight of the fragrance; 5-15% by weight of electrons; Tobok age 1-10 wt%; It may include 5-15% by weight of cornus oil and 5-15% by weight of salt.
  • a natural product including a parenthesis, gyunhyang fragrance, chacha, Tobokyeong, cornus and salt, wherein the natural product is 30 to 60% by weight of the parenthesis; 10 to 40% by weight of the fragrance; 5-15% by weight of electrons; Tobok age 1-10 wt%; It may include 5-15% by weight of cornus oil and 5-15% by weight of salt.
  • the guruucin is a main component in the natural product, and is a natural product having antibacterial, anticancer, analgesic, antitussive and antipyretic effects.
  • the guruucin is preferably included in the natural product 30 to 60% by weight, more preferably 40 to 50% by weight, but is not limited thereto.
  • the convention fragrance is a natural product having a smooth and pain relief effect of metabolism
  • the convention fragrance is preferably included in the natural product 10 to 40% by weight, more preferably 20 to 30% by weight, but is not limited thereto.
  • the meeting fragrance is less than the above range, there is a problem that bad breath removal and antimicrobial efficacy is lowered, and when the meeting fragrance exceeds the above range, there is a problem that the efficacy according to the other components is reduced.
  • the charger is a natural product having toxins and waste removal and immunity enhancing effects, and the charger is preferably contained in an amount of 5 to 15% by weight, more preferably 5 to 10% by weight, but is not limited thereto. Do not.
  • the chager is less than the above range, there is a problem that the toxin removal, antibacterial and regeneration promoting efficacy is lowered, and when the chaeon exceeds the above range, there is a problem that the efficacy of other components is lowered.
  • the Tobokyeong is a natural product having toxins and waste removal, dermatitis alleviation and anti-aging efficacy
  • the Tobokyeong is preferably contained 1 to 10% by weight in the natural product, more preferably 1 to 5% by weight, It is not limited to this.
  • the abdomen age is less than the above range, there is a problem that the efficacy of discharging heavy metals and waste products is reduced, and when the abdomen age exceeds the above range, there is a problem that the efficacy according to other components is lowered.
  • the cornus milk is a natural product having anti-cancer, blood circulation improvement, bacterial inhibition and liver function-improving effect
  • the cornus milk is preferably contained in the natural product 5-15% by weight, more preferably 5-10% by weight, It is not limited to this.
  • the cornus milk is less than the above range, there is a problem that the antifungal, whitening, regeneration promoting and immune-enhancing efficacy is lowered, and if the cornus milk exceeds the above range, there is a problem that the efficacy according to other components is lowered.
  • the salt is a detoxifying action to remove the poison, anti-inflammatory action to remove inflammation, sterilization and antiseptic action to kill bacteria and prevent the body from rotting, and restore damaged cells.
  • the salt may be grilled salt, it is preferably included 5 to 15% by weight in the natural product, more preferably 5 to 10% by weight, but is not limited thereto. At this time, by using the salt within the above range, it is possible to balance the other components.
  • the natural product may be extracted, fermented or extracted and fermented.
  • the extraction is performed by a solvent comprising at least one selected from the group consisting of water, anhydrous or hydrous lower alcohols of 1-4 carbon atoms, lower ketones of 1-4 carbon atoms, lower esters of 1-4 carbon atoms, chloroform and mixtures thereof.
  • the content of the solid content after the extraction may be 10% to 90%, preferably 30 to 90%, more preferably 40% to 90%.
  • the extraction is performed under the optimum conditions for 60 minutes to 70 minutes at 80 °C to 90 °C, it is possible to optimize the active ingredient content in the natural product, as well as to prevent tooth decay and improve gum disease and prevent efficacy, oral It can prevent bacteria from penetrating blood vessels and causing heart disease.
  • the oral composition according to the present invention contains a vegetable oil for oil pulling, and the vegetable oil preferably includes castor oil and nim oil, but is not limited thereto.
  • Vegetable oil in the present invention includes castor oil, the castor oil (castor oil) is a fat oil obtained by pressing the seed of the castor, also called castor oil.
  • the castor oil is characterized in that the tablet contains a component of lysine (toxic protein) and lyricin (alkaloid), which has a bactericidal action, lowers swelling of the skin (soft tissue) and pus.
  • the synergistic effect can be obtained by detoxification and mixing at the proper ratio.
  • lysine it is particularly preferable in terms of detoxifying action to include 0.1-2% by weight of lysine and 0.1-2% by weight of lysine, preferably 1 ⁇ 0.1% by weight of lysine and 1 ⁇ 0.1% by weight of lysine, relative to the total weight of castor oil It is not limited to this. However, it should be noted that the lethal doses of the toxins are lysine 7mg and richin 160mg.
  • the castor oil has antiviral, antibacterial and waste excretion effects in the present invention.
  • the vegetable oil includes, in addition to castor oil, the neem oil, and the neem oil is an oil extracted from the neem tree, which is rich in fatty acids, and contains vitamin E, essential amino acids, and the like.
  • the neem oil has an antibacterial and immune enhancing effect in the present invention, and is characterized in that it contains azadirachtin and a component of nimbidin.
  • the Nim oil Compared to the total weight of the Nim oil, it is 5 to 15% by weight of azadilactin, 5 to 15% by weight of animadidine, preferably 10 ⁇ 1% by weight of azadilactin and 10 ⁇ 1% by weight of nimvidin, in particular in terms of bactericidal action Preferred but not limited thereto.
  • the neem oil may be extracted from the leaves, stems, flowers, roots, bark, fruit, seeds or mixtures thereof of the neem tree, and the extract from the bark is most preferred in terms of detoxification, but is not limited thereto.
  • the weight ratio of the castor oil and the nim oil is preferably 1: 1 to 5: 1, more preferably 1: 1 to 3: 1, but is not limited thereto. At this time, when the weight ratio of castor oil and nim oil is less than the above range, there is a problem that the effect of the sterilization action is lowered, and when the weight ratio of castor oil and nim oil exceeds the above range, there is a problem that the detoxification action is reduced.
  • the vegetable oil when the vegetable oil contains both castor oil and nim oil in a specific weight ratio, it can exert excellent sterilization and detoxification effects simultaneously. Due to this, it is possible to prevent tooth decay and gum disease improvement and prevention effect, in particular, oral bacteria can penetrate blood vessels and cause heart disease. It is preferable to contain 70 parts by weight to 90 parts by weight of the natural product and 10 parts by weight to 30 parts by weight of the vegetable oil with respect to 100 parts by weight of the oral composition, but is not limited thereto.
  • the oral composition may be for inhibiting one or more oral bacteria selected from the group consisting of Streptococcus mutans, Porphyromonas Gingivalis, and Streptococcus Gordonii.
  • the Streptococcus mutans is a major bacterium that causes tooth decay (tooth caries), and decomposes organic matter and releases acid and causes demineralization of teeth by these acids, and the porphyromonas gingivalis Porphyromonas Gingivalis) is a representative bacterium that causes gingivitis, periodontal disease, and tooth decay.
  • Streptococcus Gordonii penetrates the blood vessels of the gum and into the aorta. Streptococcus Gordonii penetrates the heart due to the inability of the immune system to act as a blood coagulation factor, fibrinogen. Can cause. In particular, chronic diseases such as arteriosclerosis and hypertension need to try to prevent heart disease by suppressing Streptococcus Gordonii.
  • the oral composition may be formulated in the form of a powder, granules, tablets, capsules, creams, transparent gels or translucent gels. That is, the oral composition is characterized in that it is not formulated in liquid form, such as in the form of a solution, suspension or emulsion, there is an advantage that can minimize the side effects of the existing oil pooling.
  • the formulation may further comprise one or more additives selected from the group consisting of suitable abrasives, wetting agents, binders, foaming agents, sweetening agents, preservatives, agonists, flavors, acidity regulators and brighteners commonly used in the manufacture of pharmaceutical compositions. have.
  • the additive is preferably included in an amount of 0.01 to 10 parts by weight based on 100 parts by weight of the oral composition, but is not limited thereto.
  • the abrasive may be one or more selected from the group consisting of calcium monohydrogen phosphate, precipitated silica, calcium carbonate, hydrous alumina, kaolin and sodium bicarbonate, preferably calcium monohydrogen phosphate or precipitated silica.
  • the wetting agent may be at least one selected from the group consisting of glycerin, sorbitol, amorphous sorbitol liquid, propylene glycol, polyethylene glycol, and xylitol, and preferably sorbitol.
  • the binder is sodium carboxymethyl cellulose, carrageenan, xanthan gum, hydroxyethyl cellulose, hydroxypropylmethylcellulose, hydroxypropyl cellulose, guar gum, gellan gum, carbomer, pectin, polyvinylpyrrolidone, carboxyvinyl poly It may be one or more selected from the group consisting of sodium alginate and laponite, preferably sodium carboxymethyl cellulose.
  • foaming agent examples include anionic surfactants such as sodium lauryl sulfate and sodium lauryl sarcosinate, C12-20 alkyl glucosides, sorbitan fatty acid esters, polyoxyethylene-cured castor oil, and polyoxyethylene-polyoxypropylene copolymers. It may be at least one selected from the group consisting of nonionic surfactants or amphoteric surfactants such as cocoidopropylbetaine, preferably C12-20 alkyl glucoside.
  • anionic surfactants such as sodium lauryl sulfate and sodium lauryl sarcosinate, C12-20 alkyl glucosides, sorbitan fatty acid esters, polyoxyethylene-cured castor oil, and polyoxyethylene-polyoxypropylene copolymers. It may be at least one selected from the group consisting of nonionic surfactants or amphoteric surfactants such as cocoidopropylbetaine, preferably C12-20 al
  • C12-20 alkyl glucoside is a condensation reaction of C12-20 alcohol and glucose, and may help to disperse and emulsify the immiscible components by adsorbing at the interface of the components to reduce the surface tension.
  • the sweetener may be at least one selected from the group consisting of sodium saccharin, sucralose, maltitol, aspartame, erythritol, and licoriceic acid, preferably sodium saccharin.
  • the natural preservative may be one or more selected from the group consisting of grapefruit seed extract (GSE), napri (NAPRE) and lavender.
  • GSE grapefruit seed extract
  • NAPRE napri
  • the grapefruit seed extract is characterized in that it has a bactericidal, disinfecting and antiseptic effect
  • napri is a herbal medicine of Sancho, moss, Baekduhong, can have an additional antiseptic effect of about 3 months, no problems due to troubles and other raw materials
  • lavender is a typical natural preservative is a feature that can have a stable storage date to some extent even if it does not contain other preservatives separately.
  • It may be at least one selected from the group consisting of paraoxybenzoic acid ester and sodium benzoate as an artificial preservative. More preferably, grapefruit seed extract or napri (NAPRE) is used as the preservative, but is not limited thereto.
  • NAPRE grapefruit seed extract or napri
  • the medicament agents include sodium fluoride, sodium fluoride phosphate, monofluoride, fluorinated amine, chlorhexidine, aminocaproic acid, dipotassium glycyrizine, tranexamic acid, allotoin, capronic acid, polyphosphate, enzymes and herbal extract It may be at least one selected from the group consisting of, preferably sodium fluoride.
  • the fragrance is used by mixing an appropriate amount of natural flavors such as peppermint oil, spearmint oil and synthetic flavors such as menthol, carbon, and preferably, an appropriate amount of anise oil may be mixed with the fragrance mixed with a certain ratio.
  • the present invention comprises the steps of (a) extracting the natural product, including the parenthesis, gyunyanghyang, chajeon, Tobokyeong, cornus and salt to prepare an extract, fermented extract or extract fermentation; And (b) provides a method for producing an oral composition comprising the step of adding and mixing the vegetable oil to the extract, fermented extract or extract fermentation.
  • the step (a) is a step of preparing an extract, fermented extract or extractive fermentation product by extracting natural products including gwalyeoin, gyunyanghyang, chajeon, Tobokyeong, cornus and salt, the extraction is water, carbon number 1-4 Anhydrous or hydrous lower alcohols, lower ketones of 1-4 carbon atoms, lower esters of 1-4 carbon atoms, chloroform, and mixtures thereof. It is preferably performed for from minutes to 70 minutes in terms of optimizing the active ingredient content in the natural product, but is not limited thereto. Fermentation may be added before and after the extraction.
  • the weight ratio of the natural product and the solvent is preferably 1:30 to 1:10, but is not limited thereto.
  • the step (b) is a step of adding and mixing the vegetable oil to the extract, fermented extract or fermentation extract, the vegetable oil preferably includes castor oil and nim oil, but is not limited thereto.
  • the addition may be carried out according to conventional methods in the above-mentioned content.
  • composition for oral cavity containing natural and vegetable oils according to the present invention is excellent in inhibiting both Streptococcus mutans, Porphyromonas Gingivalis and Streptococcus Gordonii. Bars, caries prevention and gum disease improvement and prevention efficacy is excellent, as well as oral bacteria can be prevented from penetrating blood vessels and causing heart disease.
  • Natural products and water including 1 part by weight of kwaruin, 0.5 part by weight of crab, 0.2 part by weight of chacha, 0.1 part by weight of Tobok-ryong, 0.2 part by weight of cornus oil and 0.2 part by weight of grilled salt, were mixed at 85 ° C. in a 1:19 weight ratio for 65 minutes. Extraction to prepare an extract (containing 50% solids). To 85 parts by weight of the prepared extract as a vegetable oil, 10 parts by weight of castor oil and 5 parts by weight of nim oil were added and mixed to prepare an oral composition.
  • an oral composition was prepared in the same manner as in Example 1, except that 10 parts by weight of castor oil and 5 parts by weight of nim oil were omitted.
  • an oral composition was prepared by mixing 10 parts by weight of castor oil and 5 parts by weight of nim oil.
  • Example 1 As shown in Table 1, the oral composition prepared in Example 1 is compared to the oral compositions prepared in Comparative Examples 1 and 2, Streptococcus mutans, Porphyromonas Gingivalis and Streptococcus It was confirmed that all of the inhibitory effects of Streptococcus Gordonii were excellent. Therefore, it was confirmed that not only caries prevention but also gum disease improvement and prevention efficacy were particularly excellent.
  • the oral composition prepared in Example 1 has a particularly excellent effect of inhibiting Streptococcus Gordonii, compared to the oral compositions prepared in Comparative Examples 1 and 2, and Streptococcus Gordonii penetrates into blood vessels. It was confirmed that it can also prevent the occurrence of heart disease.
  • Example 2 To evaluate the efficacy of the oral composition prepared in Example 1 as a health supplement toothpaste, the health supplemental toothpaste of the oral composition prepared in Example was administered to 50 adult men and women who complained or diagnosed symptoms such as tooth decay and gum disease. Three times a day was used continuously for about six months, the effect was evaluated by a survey, the results are shown in Table 2 below.
  • the health supplement toothpaste of the oral composition prepared in the embodiment was found to be particularly excellent in reducing gum inflammation and effectively inhibiting oral bacteria, as well as preventing tooth decay and improving gum disease.
  • Example 1 is a photograph comparing the degree of gum inflammation in vivo (a) and steadily using for about 30 days before (a) and three times a day before using the health supplement toothpaste of the oral composition prepared in Example 1.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to an oral composition containing: a natural substance comprising trichosanthes seeds, fennel seeds, plantago seeds, Smilax glabra, cornus fruit and a salt; and vegetable oil, and a method for preparing the same.

Description

구강용 조성물 및 이의 제조방법Oral composition and preparation method thereof
본 출원은 2015년 11월 18일 출원된 대한민국 특허출원 제10-2015-0161974 호를 우선권으로 주장하고, 상기 명세서 전체는 본 출원의 참고문헌이다. This application claims the priority of Korean Patent Application No. 10-2015-0161974 filed on November 18, 2015, the entirety of which is a reference of the present application.
본 발명은 구강용 조성물 및 이의 제조방법에 관한 것이다.The present invention relates to a composition for oral cavity and a method for producing the same.
구강 세균은 플라그(plaque)를 형성하게 되는데 치아 전체에 걸쳐 생성되고 특히 잇몸과 치아 사이에 있는 플라그는 통상적인 칫솔질에 의해 잘 제거되지 않을 뿐만 아니라 석회화되어 치석으로 변하게 되어 충치와 잇몸 질환을 유발시키는 원인이 된다. 이러한 구강 세균은 지방막 또는 지질막에 둘러싸여 있다. Oral bacteria form plaques, which are formed throughout the teeth, especially those between the gums and the teeth that are not easily removed by conventional brushing, but also calcified and turn into tartar causing dental caries and gum disease. Cause. These oral bacteria are surrounded by fat or lipid membranes.
한편, 오일 풀링은 인도의 전통 의학서인 '아유르베다'에 소개된 것으로, 구강 세균을 없애기 위한 천연 가글 용액으로서, 오일에 구강 세균을 흡착시켜 몸 속의 독소를 배출시키는 원리이다. 오일 풀링은 주로 코코넛 오일 또는 올리브 오일 등을 한 스푼 입안에 넣은 다음, 약 20분 동안 가글하는 방법으로 수행된다.Meanwhile, oil pooling was introduced in Ayurveda, a traditional Indian medicine book, and is a natural goggle solution for removing oral bacteria, and it is a principle of releasing toxins in the body by adsorbing oral bacteria in oil. Oil pooling is usually done by putting coconut oil or olive oil in a spoonful of mouth and gargle for about 20 minutes.
다만, 오일 풀링의 부작용으로써, 오일 중 일부가 목 뒤로 넘어가게 되는 경우 폐렴을 일으킬 수 있다는 문제점이 있고, 입안에 상처가 있으면 상처를 통해 오히려 세균에 감염될 수 있으며, 치아에 아말감이나 금속이 있으면 냉압착 올리브 오일 사용 시간을 단축시켜야 한다는 문제점이 있다. However, as a side effect of oil pooling, if some of the oil passes over the back of the neck, it may cause pneumonia. If there is a wound in the mouth, it may be rather infected with bacteria through the wound, and if there is amalgam or metal in the teeth, There is a problem in that the use of cold press olive oil should be shortened.
본 발명은 괄루인, 대회향, 차전자, 토복령, 산수유 및 소금을 포함하는 천연물; 및 식물성 오일을 함유하는 구강 조성물 등을 제공하고자 한다. The present invention is a natural product, including the parenthesis, gyunyanghyang, chajeon, Tobokyeong, cornus and salt; And oral compositions containing vegetable oils.
또한, 본 발명은 괄루인, 대회향, 차전자, 토복령, 산수유 및 소금을 포함하는 천연물; 및 식물성 오일을 함유하는 구강 조성물을 투여하는 것을 포함하는 충치예방과 잇몸 질환 개선 및 예방하기 위한 방법을 제공하고자 한다.In addition, the present invention is a natural product, including the parenthesis, gyunyanghyang, chajeon, Tobokyeong, cornus and salt; And to provide a method for preventing caries and gum disease improvement and prevention comprising administering an oral composition containing a vegetable oil.
더 나아가, 본 발명은 충치예방과 잇몸 질환 개선 및 예방용 치료제의 제조를 위한 괄루인, 대회향, 차전자, 토복령, 산수유 및 소금을 포함하는 천연물; 및 식물성 오일을 함유하는 구강 조성물의 용도를 제공하고자 한다. Furthermore, the present invention is a natural product, including a balsamin, competition fragrances, chajeonja, bokbokyeong, cornus and salt for the prevention of tooth decay and gum disease improvement and production of a preventive agent; And oral compositions containing vegetable oils.
그러나, 본 발명이 이루고자 하는 기술적 과제는 이상에서 언급한 과제에 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 당업자에게 명확하게 이해될 수 있을 것이다.However, the technical problem to be achieved by the present invention is not limited to the above-mentioned problem, another task that is not mentioned will be clearly understood by those skilled in the art from the following description.
본 발명의 일 구현예로, 괄루인, 대회향, 차전자, 토복령, 산수유 및 소금을 포함하는 천연물; 및 식물성 오일을 함유하는 구강 조성물을 제공한다.In one embodiment of the present invention, natural products, including gug luin, convention fragrance, chajeon, Tobokyeong, cornus and salt; And oral compositions containing vegetable oils.
상기 천연물은 괄루인 30~60 중량%; 대회향 10~40 중량%; 차전자 5~15 중량%; 토복령 1~10 중량%; 산수유 5~15 중량% 및 소금 5~15 중량%를 포함할 수 있다.The natural product is 30 to 60% by weight of the guru; 10 to 40% by weight of the fragrance; 5-15% by weight of electrons; Tobok age 1-10 wt%; It may include 5-15% by weight of cornus oil and 5-15% by weight of salt.
상기 천연물은 추출되거나, 발효추출되거나, 추출발효될 수 있다.The natural product may be extracted, fermented or extracted and fermented.
상기 추출은 물, 탄소수 1-4의 무수 또는 함수 저급 알코올, 탄소수 1-4의 저급 케톤, 탄소수 1-4의 저급 에스테르, 클로로포름 및 이들의 혼합물로 이루어진 군으로부터 선택된 하나 이상을 포함하는 용매에 의해 이루어질 수 있다.The extraction is performed by a solvent comprising at least one selected from the group consisting of water, anhydrous or hydrous lower alcohols of 1-4 carbon atoms, lower ketones of 1-4 carbon atoms, lower esters of 1-4 carbon atoms, chloroform and mixtures thereof. Can be done.
상기 식물성 오일은 피마자 오일 및 님 오일을 포함할 수 있다. The vegetable oil may include castor oil and nim oil.
상기 피마자 오일 및 상기 님 오일의 중량비는 1:1 내지 5:1일 수 있다.The weight ratio of the castor oil and the nim oil may be 1: 1 to 5: 1.
상기 구강 조성물 100 중량부에 대하여, 상기 천연물 70 중량부 내지 90 중량부 및 상기 식물성 오일 10 중량부 내지 30 중량부를 함유할 수 있다.With respect to 100 parts by weight of the oral composition, it may contain 70 parts by weight to 90 parts by weight of the natural product and 10 parts by weight to 30 parts by weight of the vegetable oil.
상기 구강 조성물은 스트렙토코커스 뮤탄스(Streptococcus mutans), 포르피로모나스 진지발리스(Porphyromonas Gingivalis) 및 스트렙토코커스 고도니(Streptococcus Gordonii)로 이루어진 군으로부터 선택된 하나 이상의 구강 세균을 억제하기 위한 것일 수 있다.The oral composition may be for inhibiting one or more oral bacteria selected from the group consisting of Streptococcus mutans, Porphyromonas Gingivalis, and Streptococcus Gordonii.
상기 구강 조성물은 산제, 과립제, 정제, 캡슐제, 크림제, 투명겔제 또는 반투명겔제의 형태로 제형된 것일 수 있다.The oral composition may be formulated in the form of a powder, granules, tablets, capsules, creams, transparent gels or translucent gels.
본 발명의 다른 구현예로, (a) 괄루인, 대회향, 차전자, 토복령, 산수유 및 소금을 포함하는 천연물을 추출하여 추출물, 발효추출물 또는 추출발효물을 제조하는 단계; 및 (b) 상기 추출물, 발효추출물 또는 추출발효물에 식물성 오일을 첨가하고 혼합하는 단계를 포함하는 구강 조성물의 제조방법을 제공한다.In another embodiment of the present invention, (a) extracting a natural product, including the parenthesis, gyunyanghyang, chajeonja, Tobokyeong, cornus and salt to prepare an extract, fermented extract or extract fermentation; And (b) provides a method for producing an oral composition comprising the step of adding and mixing the vegetable oil to the extract, fermented extract or extract fermentation.
상기 (a) 단계에서 추출은 80℃ 내지 90℃에서 60분 내지 70분 동안 수행될 수 있다.Extraction in step (a) may be performed for 60 to 70 minutes at 80 ℃ to 90 ℃.
상기 (b) 단계에서 식물성 오일은 피마자 오일 및 님 오일을 포함할 수 있다.The vegetable oil in step (b) may include castor oil and nim oil.
본 발명에 따른 천연물 및 식물성 오일을 함유하는 구강용 조성물은 스트렙토코커스 뮤탄스(Streptococcus mutans), 포르피로모나스 진지발리스(Porphyromonas Gingivalis) 및 스트렙토코커스 고도니(Streptococcus Gordonii) 억제 효능이 모두 뛰어난바, 충치 예방과 잇몸 질환 개선 및 예방 효능이 우수할 뿐만 아니라, 구강 세균이 혈관에 침투하여 심장병을 발생시키는 것을 방지할 수 있다.Oral compositions containing natural and vegetable oils according to the present invention are excellent in inhibiting both Streptococcus mutans, Porphyromonas Gingivalis and Streptococcus Gordonii, In addition to excellent caries prevention and gum disease prevention and prevention efficacy, oral bacteria can penetrate blood vessels and prevent heart disease.
도 1은 실시예 1에서 제조된 구강 조성물의 건강 보조 치약을 사용하기 전 (a) 및 하루 3번씩 약 30일간 꾸준히 사용한 후 (b) in vivo에서 잇몸 염증 정도를 비교한 사진이다.1 is a photograph comparing the degree of gum inflammation in vivo (b) in vivo after (a) and steadily using for about 30 days three times a day before using the health supplement toothpaste of the oral composition prepared in Example 1.
본 발명자들은 오일 풀링 효과는 극대화시키면서 부작용은 최소화시키기 위한, 특정 천연물 및 식물성 오일을 함유하는 구강용 조성물을 제조하였고, 이의 충치 예방과 잇몸 질환 개선 및 예방 효능을 연구하였다. The present inventors prepared a composition for oral cavity containing specific natural products and vegetable oils in order to maximize the oil pooling effect while minimizing side effects, and studied caries prevention and gum disease improvement and prevention efficacy.
본 발명은 괄루인, 대회향, 차전자, 토복령, 산수유 및 소금을 포함하는 천연물; 및 식물성 오일을 함유하는 구강 조성물을 제공한다. The present invention is a natural product, including the parenthesis, gyunyanghyang, chajeon, Tobokyeong, cornus and salt; And oral compositions containing vegetable oils.
먼저, 본 발명에 따른 구강 조성물은 천연물 및 식물성 오일을 함유하는 것으로, 오일 풀링 효과를 극대화시키기 위해, 식물성 오일에 음(-)에너지 형태를 가지는 천연물을 첨가함으로써, 양(+)에너지 형태를 가지는 구강 세균 등을 자석처럼 강하게 흡착시켜 몸 속의 독소를 배출시킬 수 있다. First, the oral composition according to the present invention contains a natural product and a vegetable oil, in order to maximize the oil pooling effect, by adding a natural product having a negative energy form to the vegetable oil, having a positive energy form Oral bacteria can be strongly adsorbed like magnets to release toxins from the body.
구체적으로, 본 발명에 따른 구강 조성물은 괄루인, 대회향, 차전자, 토복령, 산수유 및 소금을 포함하는 천연물을 함유하는데, 상기 천연물은 괄루인 30~60 중량%; 대회향 10~40 중량%; 차전자 5~15 중량%; 토복령 1~10 중량%; 산수유 5~15 중량% 및 소금 5~15 중량%를 포함할 수 있다.Specifically, the oral composition according to the present invention contains a natural product including a parenthesis, gyunhyang fragrance, chacha, Tobokyeong, cornus and salt, wherein the natural product is 30 to 60% by weight of the parenthesis; 10 to 40% by weight of the fragrance; 5-15% by weight of electrons; Tobok age 1-10 wt%; It may include 5-15% by weight of cornus oil and 5-15% by weight of salt.
상기 괄루인은 상기 천연물 내 주된 성분으로서, 항균, 항암, 진통, 진해 및 해열 효능을 가진 천연물이다. 상기 괄루인은 상기 천연물 내 30~60 중량% 포함되는 것이 바람직하고, 40~50 중량% 포함되는 것이 더욱 바람직하나, 이에 한정되지 않는다. 이때, 괄루인이 상기 범위 미만인 경우, 독소 제거 및 항염증 효능이 저하되는 문제점이 있고, 괄루인이 상기 범위를 초과하는 경우, 타 성분에 따른 효능이 저하되는 문제점이 있다.The guru luin is a main component in the natural product, and is a natural product having antibacterial, anticancer, analgesic, antitussive and antipyretic effects. The guru luin is preferably included in the natural product 30 to 60% by weight, more preferably 40 to 50% by weight, but is not limited thereto. At this time, when the guruin is less than the above range, there is a problem that the toxin removal and anti-inflammatory efficacy is lowered, and if the guruluin exceeds the above range, there is a problem that the efficacy according to other components is lowered.
상기 대회향은 신진대사의 원활 및 통증 완화 효능을 가진 천연물로서, 상기 대회향은 상기 천연물 내 10~40 중량% 포함되는 것이 바람직하고, 20~30 중량% 포함되는 것이 더욱 바람직하나, 이에 한정되지 않는다. 이때, 대회향이 상기 범위 미만인 경우, 구취 제거 및 항균 효능이 저하되는 문제점이 있고, 대회향이 상기 범위를 초과하는 경우, 타 성분에 따른 효능이 저하되는 문제점이 있다. The convention fragrance is a natural product having a smooth and pain relief effect of metabolism, the convention fragrance is preferably included in the natural product 10 to 40% by weight, more preferably 20 to 30% by weight, but is not limited thereto. At this time, when the meeting fragrance is less than the above range, there is a problem that bad breath removal and antimicrobial efficacy is lowered, and when the meeting fragrance exceeds the above range, there is a problem that the efficacy according to the other components is reduced.
상기 차전자는 독소와 노폐물 제거 및 면역력 증진 효능을 가진 천연물로서, 상기 차전자는 상기 천연물 내 5~15 중량% 포함되는 것이 바람직하고, 5~10 중량% 포함되는 것이 더욱 바람직하나, 이에 한정되지 않는다. 이때, 차전자가 상기 범위 미만인 경우, 독소 제거, 항균 및 재생촉진 효능이 저하되는 문제점이 있고, 차전자가 상기 범위를 초과하는 경우, 타 성분에 따른 효능이 저하되는 문제점이 있다.The charger is a natural product having toxins and waste removal and immunity enhancing effects, and the charger is preferably contained in an amount of 5 to 15% by weight, more preferably 5 to 10% by weight, but is not limited thereto. Do not. At this time, when the chager is less than the above range, there is a problem that the toxin removal, antibacterial and regeneration promoting efficacy is lowered, and when the chaeon exceeds the above range, there is a problem that the efficacy of other components is lowered.
상기 토복령은 독소와 노폐물 제거, 피부염 완화 및 항노화 효능을 가진 천연물로서, 상기 토복령은 상기 천연물 내 1~10 중량% 포함되는 것이 바람직하고, 1~5 중량% 포함되는 것이 더욱 바람직하나, 이에 한정되지 않는다. 이때, 토복령이 상기 범위 미만인 경우, 중금속 및 노폐물 배출 효능이 저하되는 문제점이 있고, 토복령이 상기 범위를 초과하는 경우, 타 성분에 따른 효능이 저하되는 문제점이 있다.The Tobokyeong is a natural product having toxins and waste removal, dermatitis alleviation and anti-aging efficacy, the Tobokyeong is preferably contained 1 to 10% by weight in the natural product, more preferably 1 to 5% by weight, It is not limited to this. At this time, when the abdomen age is less than the above range, there is a problem that the efficacy of discharging heavy metals and waste products is reduced, and when the abdomen age exceeds the above range, there is a problem that the efficacy according to other components is lowered.
상기 산수유는 항암, 혈액순환 개선, 세균 억제 및 간기능 개선 효능을 가진 천연물로서, 상기 산수유는 상기 천연물 내 5~15 중량% 포함되는 것이 바람직하고, 5~10 중량% 포함되는 것이 더욱 바람직하나, 이에 한정되지 않는다. 이때, 산수유가 상기 범위 미만인 경우, 항진균, 미백, 재생촉진 및 면역력 증강 효능이 저하되는 문제점이 있고, 산수유가 상기 범위를 초과하는 경우, 타 성분에 따른 효능이 저하되는 문제점이 있다.The cornus milk is a natural product having anti-cancer, blood circulation improvement, bacterial inhibition and liver function-improving effect, the cornus milk is preferably contained in the natural product 5-15% by weight, more preferably 5-10% by weight, It is not limited to this. At this time, if the cornus milk is less than the above range, there is a problem that the antifungal, whitening, regeneration promoting and immune-enhancing efficacy is lowered, and if the cornus milk exceeds the above range, there is a problem that the efficacy according to other components is lowered.
상기 소금은 독을 제거하는 제독(除毒) 작용, 염증을 없애주는 소염(消炎) 작용, 세균을 죽이고 몸이 썩지 않게 하는 살균(殺菌) 및 방부(防腐) 작용, 파괴된 세포를 회복시키는 작용을 하는 것으로, 상기 소금은 구운 소금일 수 있고, 상기 천연물 내 5~15 중량% 포함되는 것이 바람직하고, 5~10 중량% 포함되는 것이 더욱 바람직하나, 이에 한정되지 않는다. 이때, 소금이 상기 범위 내에서 사용됨으로써, 타 성분 간의 균형을 맞출 수 있다. The salt is a detoxifying action to remove the poison, anti-inflammatory action to remove inflammation, sterilization and antiseptic action to kill bacteria and prevent the body from rotting, and restore damaged cells. By doing so, the salt may be grilled salt, it is preferably included 5 to 15% by weight in the natural product, more preferably 5 to 10% by weight, but is not limited thereto. At this time, by using the salt within the above range, it is possible to balance the other components.
상기 천연물은 추출되거나, 발효추출되거나, 추출발효될 수 있다.The natural product may be extracted, fermented or extracted and fermented.
상기 추출은 물, 탄소수 1-4의 무수 또는 함수 저급 알코올, 탄소수 1-4의 저급 케톤, 탄소수 1-4의 저급 에스테르, 클로로포름 및 이들의 혼합물로 이루어진 군으로부터 선택된 하나 이상을 포함하는 용매에 의해 이루어질 수 있고, 상기 추출 후 고형분의 함량은 10% 내지 90%, 바람직하게 30 내지 90%, 더욱 바람직하게 40% 내지 90%일 수 있다. The extraction is performed by a solvent comprising at least one selected from the group consisting of water, anhydrous or hydrous lower alcohols of 1-4 carbon atoms, lower ketones of 1-4 carbon atoms, lower esters of 1-4 carbon atoms, chloroform and mixtures thereof. The content of the solid content after the extraction may be 10% to 90%, preferably 30 to 90%, more preferably 40% to 90%.
상기 추출은 80℃ 내지 90℃에서 60분 내지 70분 동안 최적의 조건으로 수행됨으로써, 상기 천연물 내 유효 성분 함량을 최적화시킬 수 있어, 충치 예방과 잇몸 질환 개선 및 예방 효능이 우수할 뿐만 아니라, 구강 세균이 혈관에 침투하여 심장병을 발생시키는 것을 방지할 수 있다.The extraction is performed under the optimum conditions for 60 minutes to 70 minutes at 80 ℃ to 90 ℃, it is possible to optimize the active ingredient content in the natural product, as well as to prevent tooth decay and improve gum disease and prevent efficacy, oral It can prevent bacteria from penetrating blood vessels and causing heart disease.
또한, 본 발명에 따른 구강 조성물은 오일 풀링을 위한 식물성 오일을 함유하는 것으로, 상기 식물성 오일은 피마자 오일 및 님 오일을 포함하는 것이 바람직하나, 이에 한정되지 않는다. In addition, the oral composition according to the present invention contains a vegetable oil for oil pulling, and the vegetable oil preferably includes castor oil and nim oil, but is not limited thereto.
본 발명에서 식물성 오일은 피마자 오일을 포함하는데, 상기 피마자 오일(castor oil)은 피마자의 종자를 압착하여 얻는 지방유로, 아주까리 기름이라고도 한다. 또한, 상기 피마자 오일은 살균작용을 하는 리친(ricin)(독성 단백질)과 리치닌(ricinine)(알칼로이드)의 성분을 정제 함유하고 있는 것을 특징으로 하는바, 피부(연조직)의 부종을 내리고 고름을 배출시키며 해독을 하여 적절한 비율로 혼합했을 때 상승효과를 얻을 수 있다. 상기 피마자 오일 전체 중량 대비, 리친 0.1~2 중량% 및 리치닌 0.1~2 중량%, 바람직하게 리친 1±0.1 중량% 및 리치닌 1±0.1 중량% 포함하는 것이, 해독 작용의 측면에서 특히 바람직하나, 이에 한정되지 않는다. 다만, 피미자 독의 치사량은 어른 기준으로 리친 7mg, 리치닌 160mg임을 유의하여야 한다. 상기 피마자 오일은 본 발명에서 항바이러스, 항균 및 노폐물 배출 효능을 가진다. Vegetable oil in the present invention includes castor oil, the castor oil (castor oil) is a fat oil obtained by pressing the seed of the castor, also called castor oil. In addition, the castor oil is characterized in that the tablet contains a component of lysine (toxic protein) and lyricin (alkaloid), which has a bactericidal action, lowers swelling of the skin (soft tissue) and pus. The synergistic effect can be obtained by detoxification and mixing at the proper ratio. It is particularly preferable in terms of detoxifying action to include 0.1-2% by weight of lysine and 0.1-2% by weight of lysine, preferably 1 ± 0.1% by weight of lysine and 1 ± 0.1% by weight of lysine, relative to the total weight of castor oil It is not limited to this. However, it should be noted that the lethal doses of the toxins are lysine 7mg and richin 160mg. The castor oil has antiviral, antibacterial and waste excretion effects in the present invention.
본 발명에서 식물성 오일은 피마자 오일 외에, 님 오일을 포함하는데, 상기 님 오일(neem oil)은 님나무로부터 추출된 오일로서, 님나무에는 지방산이 풍부하며, 비타민 E, 필수 아미노산 등을 함유하고 있으므로, 상기 님 오일은 본 발명에서 항균 및 면역력 증강 효능을 가지며, 아자디락틴(azadirachtin)과 님비딘(nimbidin)의 성분을 정제 함유하고 있는 것을 특징으로 한다. 상기 님 오일 전체 중량 대비, 아자디락틴 5~15 중량%, 님비딘 5~15중량 바람직하게 아자디락틴 10±1 중량% 및 님비딘 10±1 중량% 포함하는 것이, 살균 작용의 측면에서 특히 바람직하나, 이에 한정되지 않는다. 상기 님 오일은 님나무의 잎, 줄기, 꽃, 뿌리, 껍질, 열매, 씨 또는 이들의 혼합물로부터 추출될 수 있으며, 껍질로부터 추출되는 것이 해독 작용 측면에서 가장 바람직하나, 이에 한정되지 않는다. In the present invention, the vegetable oil includes, in addition to castor oil, the neem oil, and the neem oil is an oil extracted from the neem tree, which is rich in fatty acids, and contains vitamin E, essential amino acids, and the like. In addition, the neem oil has an antibacterial and immune enhancing effect in the present invention, and is characterized in that it contains azadirachtin and a component of nimbidin. Compared to the total weight of the Nim oil, it is 5 to 15% by weight of azadilactin, 5 to 15% by weight of animadidine, preferably 10 ± 1% by weight of azadilactin and 10 ± 1% by weight of nimvidin, in particular in terms of bactericidal action Preferred but not limited thereto. The neem oil may be extracted from the leaves, stems, flowers, roots, bark, fruit, seeds or mixtures thereof of the neem tree, and the extract from the bark is most preferred in terms of detoxification, but is not limited thereto.
상기 피마자 오일 및 상기 님 오일의 중량비는 1:1 내지 5:1인 것이 바람직하고, 1:1 내지 3:1인 것이 더욱 바람직하나, 이에 한정되지 않는다. 이때, 피마자 오일 및 님 오일의 중량비가 상기 범위 미만인 경우, 살균 작용의 효과가 저하되는 문제점이 있고, 피마자 오일 및 님 오일의 중량비가 상기 범위를 초과하는 경우, 해독 작용이 저하되는 문제점이 있다. The weight ratio of the castor oil and the nim oil is preferably 1: 1 to 5: 1, more preferably 1: 1 to 3: 1, but is not limited thereto. At this time, when the weight ratio of castor oil and nim oil is less than the above range, there is a problem that the effect of the sterilization action is lowered, and when the weight ratio of castor oil and nim oil exceeds the above range, there is a problem that the detoxification action is reduced.
즉, 상기 식물성 오일이 피마자 오일 및 님 오일을 특정 중량비로 모두 포함하는 경우, 탁월한 살균 및 해독 작용을 동시에 발휘할 수 있다. 이로 인하여, 충치 예방과 잇몸 질환 개선 및 예방 효능과 함께, 특히, 구강 세균이 혈관에 침투하여 심장병을 발생시키는 것을 방지할 수 있다. 상기 구강 조성물 100 중량부에 대하여, 상기 천연물 70 중량부 내지 90 중량부 및 상기 식물성 오일 10 중량부 내지 30 중량부를 함유하는 것이 바람직하나, 이에 한정되지 않는다. That is, when the vegetable oil contains both castor oil and nim oil in a specific weight ratio, it can exert excellent sterilization and detoxification effects simultaneously. Due to this, it is possible to prevent tooth decay and gum disease improvement and prevention effect, in particular, oral bacteria can penetrate blood vessels and cause heart disease. It is preferable to contain 70 parts by weight to 90 parts by weight of the natural product and 10 parts by weight to 30 parts by weight of the vegetable oil with respect to 100 parts by weight of the oral composition, but is not limited thereto.
상기 구강 조성물은 스트렙토코커스 뮤탄스(Streptococcus mutans), 포르피로모나스 진지발리스(Porphyromonas Gingivalis) 및 스트렙토코커스 고도니(Streptococcus Gordonii)로 이루어진 군으로부터 선택된 하나 이상의 구강 세균을 억제하기 위한 것일 수 있다. The oral composition may be for inhibiting one or more oral bacteria selected from the group consisting of Streptococcus mutans, Porphyromonas Gingivalis, and Streptococcus Gordonii.
상기 스트렙토코커스 뮤탄스(Streptococcus mutans)는 충치(치아우식)를 유발하는 주된 세균으로서, 유기물을 분해하여 산을 배출하며 이러한 산에 의해 치아가 탈회되는 현상을 일으키고, 상기 포르피로모나스 진지발리스(Porphyromonas Gingivalis)는 구강 세균 중 치은염, 치주질환, 충치(치아우식)를 유발하는 대표적인 세균이다.The Streptococcus mutans is a major bacterium that causes tooth decay (tooth caries), and decomposes organic matter and releases acid and causes demineralization of teeth by these acids, and the porphyromonas gingivalis Porphyromonas Gingivalis) is a representative bacterium that causes gingivitis, periodontal disease, and tooth decay.
또한, 스트렙토코커스 고도니(Streptococcus Gordonii)는 잇몸 혈관에 침투하여 대동맥까지 침투하게 되는데, 스트렙토코커스 고도니(Streptococcus Gordonii)는 혈액응고인자인 피브리노겐으로 위장하기 때문에 면역시스템이 작동하지 않기 때문에, 심장병을 일으킬 수 있다. 특히, 동맥경화나 고혈압 등 만성질환자는 스트렙토코커스 고도니(Streptococcus Gordonii)의 억제를 통해 심장병 예방에 힘쓸 필요가 있다. In addition, Streptococcus Gordonii penetrates the blood vessels of the gum and into the aorta. Streptococcus Gordonii penetrates the heart due to the inability of the immune system to act as a blood coagulation factor, fibrinogen. Can cause. In particular, chronic diseases such as arteriosclerosis and hypertension need to try to prevent heart disease by suppressing Streptococcus Gordonii.
따라서, 충치 예방과 잇몸 질환 개선 및 예방 효능이 우수할 뿐만 아니라, 구강 세균이 혈관에 침투하여 심장병을 발생시키는 것을 방지할 수 있다.Therefore, it is possible to prevent tooth decay and improve gum disease and prevent efficacy, and to prevent oral bacteria from penetrating blood vessels and causing heart disease.
상기 구강 조성물은 산제, 과립제, 정제, 캡슐제, 크림제, 투명겔제 또는 반투명겔제의 형태로 제형된 것일 수 있다. 즉, 상기 구강 조성물은 용액제, 현탁액제 또는 유제의 형태 등과 같이 액상으로 제형화되지 아니한 것을 특징으로 하는바, 기존 오일 풀링의 부작용을 최소화할 수 있는 이점이 있다. 상기 제형화를 위하여 약학 조성물의 제조에 통상적으로 사용되는 적절한 연마제, 습윤제, 결합제, 기포제, 감미제, 방부제, 약효제, 향료, 산성도 조절제 및 증백제로 이루어진 군으로부터 선택된 하나 이상의 첨가제를 추가적으로 포함할 수 있다. 이때, 상기 첨가제는 상기 구강 조성물 100 중량부에 대하여, 0.01~10 중량부 포함하는 것이 바람직하나, 이에 한정되지 않는다.The oral composition may be formulated in the form of a powder, granules, tablets, capsules, creams, transparent gels or translucent gels. That is, the oral composition is characterized in that it is not formulated in liquid form, such as in the form of a solution, suspension or emulsion, there is an advantage that can minimize the side effects of the existing oil pooling. For the formulation may further comprise one or more additives selected from the group consisting of suitable abrasives, wetting agents, binders, foaming agents, sweetening agents, preservatives, agonists, flavors, acidity regulators and brighteners commonly used in the manufacture of pharmaceutical compositions. have. In this case, the additive is preferably included in an amount of 0.01 to 10 parts by weight based on 100 parts by weight of the oral composition, but is not limited thereto.
상기 연마제는 인산일수소칼슘, 침강실리카, 탄산칼슘, 함수알루미나, 카오린 및 중조로 이루어진 군으로부터 선택된 하나 이상일 수 있고, 바람직하게는 인산일수소칼슘 또는 침강실리카일 수 있다. The abrasive may be one or more selected from the group consisting of calcium monohydrogen phosphate, precipitated silica, calcium carbonate, hydrous alumina, kaolin and sodium bicarbonate, preferably calcium monohydrogen phosphate or precipitated silica.
상기 습윤제로는 글리세린, 소르비톨, 비결정성 소르비톨액, 프로필렌글리콜, 폴리에틸렌 글리콜 및 자일리톨로 이루어진 군으로부터 선택된 하나 이상일 수 있고, 바람직하게는 소르비톨일 수 있다. The wetting agent may be at least one selected from the group consisting of glycerin, sorbitol, amorphous sorbitol liquid, propylene glycol, polyethylene glycol, and xylitol, and preferably sorbitol.
상기 결합제로는 카르복시메틸셀룰로오스나트륨, 카라기난, 잔탄검, 히드록시에틸셀룰로오스, 히드록시프로필메틸셀룰로오스, 히드록시프로필셀룰로오스, 구아검, 젤란검, 카르보머, 펙틴, 폴리비닐피롤리돈, 카르복시비닐폴리며, 알긴산나트륨 및 라포나이트로 이루어진 군으로부터 선택된 하나 이상일 수 있고, 바람직하게는 카르복시메틸셀룰로오스나트륨일 수 있다.The binder is sodium carboxymethyl cellulose, carrageenan, xanthan gum, hydroxyethyl cellulose, hydroxypropylmethylcellulose, hydroxypropyl cellulose, guar gum, gellan gum, carbomer, pectin, polyvinylpyrrolidone, carboxyvinyl poly It may be one or more selected from the group consisting of sodium alginate and laponite, preferably sodium carboxymethyl cellulose.
상기 기포제로는 라우릴황산나트륨, 라우릴사르코신산나트륨 등의 음이온계면활성제와, C12~20 알킬 글루코사이드, 소르비탄 지방산에스테르, 폴리옥시에틸렌경화피마자유, 폴리옥시에틸렌-폴리옥시프로필렌계 공중합 물질 등으로 이루어진 비이온계면활성제군 또는 코코아이도프로필베타인 등의 양쪽성 계면활성제군으로부터 선택된 하나 이상일 수 있고, 바람직하게는 C12~20 알킬 글루코사이드일 수 있다. 이때, C12~20 알킬 글루코사이드는 C12~20 알코올과 글루코오스의 축합반응물로서, 성분들의 계면에 흡착하여 표면장력을 감소히킴으로써, 비혼화성 성분들의 분산과 유화에 도움을 줄 수 있다.Examples of the foaming agent include anionic surfactants such as sodium lauryl sulfate and sodium lauryl sarcosinate, C12-20 alkyl glucosides, sorbitan fatty acid esters, polyoxyethylene-cured castor oil, and polyoxyethylene-polyoxypropylene copolymers. It may be at least one selected from the group consisting of nonionic surfactants or amphoteric surfactants such as cocoidopropylbetaine, preferably C12-20 alkyl glucoside. In this case, C12-20 alkyl glucoside is a condensation reaction of C12-20 alcohol and glucose, and may help to disperse and emulsify the immiscible components by adsorbing at the interface of the components to reduce the surface tension.
상기 감미제는 사카린나트륨, 수크랄로스, 말티톨, 아스파탐, 에리스리톨 및 감초산으로 이루어진 군으로부터 선택된 하나 이상일 수 있고, 바람직하게는 사카린나트륨일 수 있다.The sweetener may be at least one selected from the group consisting of sodium saccharin, sucralose, maltitol, aspartame, erythritol, and licoriceic acid, preferably sodium saccharin.
상기 방부제로는 천연방부제 또는 인공방부제가 사용될 수 있고, 구체적으로, 천연방부제로 자몽씨 추출물(GSE), 나프리(NAPRE) 및 라벤더로 이루어진 군으로부터 선택된 하나 이상일 수 있다. 이때, 자몽씨 추출물은 살균, 소독 및 방부 효과를 가지는 것을 특징으로 하고, 나프리는 산초, 이끼, 백두홍의 생약으로서 약 3개월 정도의 추가적인 방부 효과를 가질 수 있고 트러블에 따른 문제가 없으며 기타 원료들과 호환성이 우수한 것을 특징으로 하며, 라벤더는 대표적인 천연방부제로서 다른 방부제를 별도로 포함하지 않더라도 어느 정도 안정적인 보관 기일을 가질 수 있는 특징이 있다. 인공방부제로 파라옥시안식향산에스테르 및 안식향산나트륨으로 이루어진 군으로부터 선택된 하나 이상일 수 있다. 상기 방부제로 자몽씨 추출물 또는 나프리(NAPRE)를 사용하는 것이 더욱 바람직하나, 이에 한정되지 않는다.As the preservative, natural preservatives or artificial preservatives may be used. Specifically, the natural preservative may be one or more selected from the group consisting of grapefruit seed extract (GSE), napri (NAPRE) and lavender. At this time, the grapefruit seed extract is characterized in that it has a bactericidal, disinfecting and antiseptic effect, napri is a herbal medicine of Sancho, moss, Baekduhong, can have an additional antiseptic effect of about 3 months, no problems due to troubles and other raw materials It is characterized by excellent compatibility with the field, lavender is a typical natural preservative is a feature that can have a stable storage date to some extent even if it does not contain other preservatives separately. It may be at least one selected from the group consisting of paraoxybenzoic acid ester and sodium benzoate as an artificial preservative. More preferably, grapefruit seed extract or napri (NAPRE) is used as the preservative, but is not limited thereto.
상기 약효제로는 불화나트륨, 불화인산나트륨, 불화제일석, 불화아민, 클로르헥시딘, 아미노카프로산, 글리시리진산디칼륨, 트라넥사민산, 알로토인류, 카프론산류, 폴리인산염류, 효소류 및 생약추출물로 이루어진 군으로부터 선택된 하나 이상일 수 있고, 바람직하게는 불화나트륨일 수 있다.The medicament agents include sodium fluoride, sodium fluoride phosphate, monofluoride, fluorinated amine, chlorhexidine, aminocaproic acid, dipotassium glycyrizine, tranexamic acid, allotoin, capronic acid, polyphosphate, enzymes and herbal extract It may be at least one selected from the group consisting of, preferably sodium fluoride.
상기 향료로는 페퍼민트 오일, 스피어민트 오일 등의 천연 향료와 멘톨, 카르본 등의 합성착향료를 적당량 혼합하여 사용하며, 바람직하게는 이들을 일정 비율 혼합한 향료에 아니스 오일을 적당량 혼합할 수 있다.The fragrance is used by mixing an appropriate amount of natural flavors such as peppermint oil, spearmint oil and synthetic flavors such as menthol, carbon, and preferably, an appropriate amount of anise oil may be mixed with the fragrance mixed with a certain ratio.
또한, 본 발명은 (a) 괄루인, 대회향, 차전자, 토복령, 산수유 및 소금을 포함하는 천연물을 추출하여 추출물, 발효추출물 또는 추출발효물을 제조하는 단계; 및 (b) 상기 추출물, 발효추출물 또는 추출발효물에 식물성 오일을 첨가하고 혼합하는 단계를 포함하는 구강 조성물의 제조방법을 제공한다.In addition, the present invention comprises the steps of (a) extracting the natural product, including the parenthesis, gyunyanghyang, chajeon, Tobokyeong, cornus and salt to prepare an extract, fermented extract or extract fermentation; And (b) provides a method for producing an oral composition comprising the step of adding and mixing the vegetable oil to the extract, fermented extract or extract fermentation.
상기 (a) 단계는 괄루인, 대회향, 차전자, 토복령, 산수유 및 소금을 포함하는 천연물을 추출하여 추출물, 발효추출물 또는 추출발효물을 제조하는 단계로서, 상기 추출은 물, 탄소수 1-4의 무수 또는 함수 저급 알코올, 탄소수 1-4의 저급 케톤, 탄소수 1-4의 저급 에스테르, 클로로포름 및 이들의 혼합물로 이루어진 군으로부터 선택된 하나 이상을 포함하는 용매에 의해 이루어질 수 있고, 80 내지 90에서 60분 내지 70분 동안 수행되는 것이 상기 천연물 내 유효 성분 함량 최적화 측면에서 바람직하나, 이에 한정되지 않는다. 상기 추출 전 후로 발효가 추가될 수 있다.The step (a) is a step of preparing an extract, fermented extract or extractive fermentation product by extracting natural products including gwalyeoin, gyunyanghyang, chajeon, Tobokyeong, cornus and salt, the extraction is water, carbon number 1-4 Anhydrous or hydrous lower alcohols, lower ketones of 1-4 carbon atoms, lower esters of 1-4 carbon atoms, chloroform, and mixtures thereof. It is preferably performed for from minutes to 70 minutes in terms of optimizing the active ingredient content in the natural product, but is not limited thereto. Fermentation may be added before and after the extraction.
또한, 상기 천연물 내 유효 성분 최적화 및 상기 추출 후 고형분의 함량을 고려하면, 상기 천연물 및 상기 용매의 중량비는 1:30 내지 1:10인 것이 바람직하나, 이에 한정되지 않는다. In addition, considering the optimization of the active ingredient in the natural product and the content of the solid content after the extraction, the weight ratio of the natural product and the solvent is preferably 1:30 to 1:10, but is not limited thereto.
상기 (b) 단계는 상기 추출물, 발효추출물 또는 추출발효물에 식물성 오일을 첨가하고 혼합하는 단계로서, 상기 식물성 오일은 피마자 오일 및 님 오일을 포함하는 것이 바람직하나, 이에 한정되지 않는다. 상기 첨가는 전술한 함량으로 통상적인 방법에 따라 수행될 수 있다. The step (b) is a step of adding and mixing the vegetable oil to the extract, fermented extract or fermentation extract, the vegetable oil preferably includes castor oil and nim oil, but is not limited thereto. The addition may be carried out according to conventional methods in the above-mentioned content.
따라서, 본 발명에 따른 천연물 및 식물성 오일을 함유하는 구강용 조성물은 스트렙토코커스 뮤탄스(Streptococcus mutans), 포르피로모나스 진지발리스(Porphyromonas Gingivalis) 및 스트렙토코커스 고도니(Streptococcus Gordonii) 억제 효능이 모두 뛰어난 바, 충치 예방과 잇몸 질환 개선 및 예방 효능이 우수할 뿐만 아니라, 구강 세균이 혈관에 침투하여 심장병을 발생시키는 것을 방지할 수 있다.Therefore, the composition for oral cavity containing natural and vegetable oils according to the present invention is excellent in inhibiting both Streptococcus mutans, Porphyromonas Gingivalis and Streptococcus Gordonii. Bars, caries prevention and gum disease improvement and prevention efficacy is excellent, as well as oral bacteria can be prevented from penetrating blood vessels and causing heart disease.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나 하기의 실시예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 하기 실시예에 의해 본 발명의 내용이 한정되는 것은 아니다.Hereinafter, preferred examples are provided to aid in understanding the present invention. However, the following examples are merely provided to more easily understand the present invention, and the contents of the present invention are not limited by the following examples.
[실시예]EXAMPLE
실시예 1Example 1
괄루인 1 중량부, 대회향 0.5 중량부, 차전자 0.2 중량부, 토복령 0.1 중량부, 산수유 0.2 중량부 및 구운 소금 0.2 중량부를 포함하는 천연물 및 물을 1:19 중량비로 85℃에서 65분 동안 추출하여 추출물(고형분 50% 함유)을 제조하였다. 제조된 추출물 85 중량부에 식물성 오일로서, 피마자 오일 10 중량부 및 님 오일 5 중량부를 첨가하고 혼합하여 구강 조성물을 제조하였다.Natural products and water, including 1 part by weight of kwaruin, 0.5 part by weight of crab, 0.2 part by weight of chacha, 0.1 part by weight of Tobok-ryong, 0.2 part by weight of cornus oil and 0.2 part by weight of grilled salt, were mixed at 85 ° C. in a 1:19 weight ratio for 65 minutes. Extraction to prepare an extract (containing 50% solids). To 85 parts by weight of the prepared extract as a vegetable oil, 10 parts by weight of castor oil and 5 parts by weight of nim oil were added and mixed to prepare an oral composition.
비교예 1Comparative Example 1
식물성 오일로서, 피마자 오일 10 중량부 및 님 오일 5 중량부의 첨가 및 혼합을 생략한 것을 제외하고는, 실시예 1과 동일한 방법으로 구강 조성물을 제조하였다.As the vegetable oil, an oral composition was prepared in the same manner as in Example 1, except that 10 parts by weight of castor oil and 5 parts by weight of nim oil were omitted.
비교예 2Comparative Example 2
식물성 오일로서, 피마자 오일 10 중량부 및 님 오일 5 중량부를 혼합하여 구강 조성물을 제조하였다.As the vegetable oil, an oral composition was prepared by mixing 10 parts by weight of castor oil and 5 parts by weight of nim oil.
실험예 1Experimental Example 1
비교예 1 및 2에서 제조된 구강 조성물 대비 실시예 1에서 제조된 구강 조성물의 스트렙토코커스 뮤탄스(Streptococcus mutans), 포르피로모나스 진지발리스(Porphyromonas Gingivalis) 및 스트렙토코커스 고도니(Streptococcus Gordonii) 억제 효능을 비교하고자, 바이오스펙스트럼 생명과학 연구소에 의뢰하여 항균 효능 시험(디스크 디퓨전 시험)을 수행하였다(2015년 9월 1일 내지 2015년 9월 25일). 이때, 대조군으로 0.1% NaF를 사용하였고, 그 결과는 아래 표 1에 나타내었다.Inhibitory Effect of the Oral Compositions Prepared in Example 1 Compared to the Oral Compositions Prepared in Comparative Examples 1 and 2, Streptococcus mutans, Porphyromonas Gingivalis and Streptococcus Gordonii To compare the results, an antimicrobial efficacy test (disk diffusion test) was performed by the Biospectrum Life Science Institute (September 1, 2015 to September 25, 2015). At this time, 0.1% NaF was used as a control, and the results are shown in Table 1 below.
Clear zone의 크기(mm)Clear zone size (mm)
스트렙토코커스 뮤탄스(Streptococcus mutans)Streptococcus mutans 포르피로모나스 진지발리스(Porphyromonas Gingivalis)Porphyromonas Gingivalis 스트렙토코커스 고도니(Streptococcus Gordonii)Streptococcus Gordonii
실시예 1Example 1 2020 1414 1414
비교예 1Comparative Example 1 1515 1111 00
비교예 2Comparative Example 2 1818 1313 00
대조군Control 1818 2020 1515
상기 표 1에서 보듯이, 실시예 1에서 제조된 구강 조성물은 비교예 1 및 2에서 제조된 구강 조성물 대비, 스트렙토코커스 뮤탄스(Streptococcus mutans), 포르피로모나스 진지발리스(Porphyromonas Gingivalis) 및 스트렙토코커스 고도니(Streptococcus Gordonii) 억제 효능이 모두 뛰어남을 확인할 수 있었다. 따라서, 충치 예방 뿐만 아니라 잇몸 질환 개선 및 예방 효능이 특히 우수함을 확인할 수 있었다.As shown in Table 1, the oral composition prepared in Example 1 is compared to the oral compositions prepared in Comparative Examples 1 and 2, Streptococcus mutans, Porphyromonas Gingivalis and Streptococcus It was confirmed that all of the inhibitory effects of Streptococcus Gordonii were excellent. Therefore, it was confirmed that not only caries prevention but also gum disease improvement and prevention efficacy were particularly excellent.
또한, 실시예 1에서 제조된 구강 조성물은 비교예 1 및 2에서 제조된 구강 조성물 대비, 스트렙토코커스 고도니(Streptococcus Gordonii) 억제 효능이 특히 우수한바, 스트렙토코커스 고도니(Streptococcus Gordonii)가 혈관에 침투하여 심장병을 발생시키는 것 역시 방지할 수 있음을 확인할 수 있었다. In addition, the oral composition prepared in Example 1 has a particularly excellent effect of inhibiting Streptococcus Gordonii, compared to the oral compositions prepared in Comparative Examples 1 and 2, and Streptococcus Gordonii penetrates into blood vessels. It was confirmed that it can also prevent the occurrence of heart disease.
실험예 2Experimental Example 2
실시예 1에서 따른 제조된 구강 조성물의 건강 보조 치약으로서의 효능을 평가하고자, 충치, 잇몸질환 등의 증상을 호소하거나 진단되는 성인남녀 50명을 대상으로 실시예에서 제조된 구강 조성물의 건강 보조 치약을 하루 3번씩 약 6개월간 꾸준히 사용하도록 하고, 설문조사에 의해 효과를 평가하였고, 그 결과는 하기 표 2에 나타내었다.To evaluate the efficacy of the oral composition prepared in Example 1 as a health supplement toothpaste, the health supplemental toothpaste of the oral composition prepared in Example was administered to 50 adult men and women who complained or diagnosed symptoms such as tooth decay and gum disease. Three times a day was used continuously for about six months, the effect was evaluated by a survey, the results are shown in Table 2 below.
질환명Disease name 효과 없음no effect 효과 있음In effect 상당한 효과 있음Significant effect
충치 예방 효과Caries prevention effect 3명(6%)3 people (6%) 15명(30%)15 people (30%) 32명(64%)32 people (64%)
잇몸질환 개선 및 예방 효과Improve and prevent gum disease 4~5명(8~10%)4 to 5 people (8 to 10%) 10명(20%)10 people (20%) 37명(74%)37 people (74%)
상기 표 2에서 보듯이, 실시예에서 제조된 구강 조성물의 건강보조치약은 잇몸 염증을 완화시키고 구강 세균을 효과적으로 억제하여 충치 예방 뿐만 아니라 잇몸 질환 개선 및 예방 효능이 특히 우수함을 확인할 수 있었다.As shown in Table 2, the health supplement toothpaste of the oral composition prepared in the embodiment was found to be particularly excellent in reducing gum inflammation and effectively inhibiting oral bacteria, as well as preventing tooth decay and improving gum disease.
도 1은 실시예 1에서 제조된 구강 조성물의 건강 보조 치약을 사용하기 전 (a) 및 하루 3번씩 약 30일간 꾸준히 사용한 후 (b), in vivo에서 잇몸 염증 정도를 비교한 사진이다. 1 is a photograph comparing the degree of gum inflammation in vivo (a) and steadily using for about 30 days before (a) and three times a day before using the health supplement toothpaste of the oral composition prepared in Example 1.
도 1에 나타난 바와 같이, 임플란트 커버 주변으로 노란 잇몸 염증이 생겨있는 상태의 환자(1951년생, 여자)가 실시예 1에서 제조된 구강조성물의 건강 보조 치약을 하루 3번씩 약 30일간 꾸준히 사용한 결과, 임플란트 커버 주변으로 노란 잇몸 염증이 사라짐을 확인할 수 있었다. As shown in Figure 1, a patient (born in 1951, female) in the state of yellow gum inflammation around the implant cover as a result of using the health supplement toothpaste of the oral composition prepared in Example 1 for about 30 days three times a day, Yellow gum inflammation disappeared around the implant cover.
전술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. The foregoing description of the present invention is intended for illustration, and it will be understood by those skilled in the art that the present invention may be easily modified in other specific forms without changing the technical spirit or essential features of the present invention. will be. Therefore, it should be understood that the embodiments described above are exemplary in all respects and not restrictive.

Claims (12)

  1. 괄루인, 대회향, 차전자, 토복령, 산수유 및 소금을 포함하는 천연물; 및Natural products, including walnuts, scents, chajeon, Tobokyeong, cornus and salt; And
    식물성 오일을 함유하는Containing vegetable oils
    구강 조성물.Oral composition.
  2. 제1항에 있어서,The method of claim 1,
    상기 천연물은 괄루인 30~60 중량%; 대회향 10~40 중량%; 차전자 5~15 중량%; 토복령 1~10 중량%; 산수유 5~15 중량% 및 소금 5~15 중량%를 포함하는The natural product is 30 to 60% by weight of the guru; 10 to 40% by weight of the fragrance; 5-15% by weight of electrons; Tobok age 1-10 wt%; Comprising 5-15% by weight of cornus oil and 5-15% by weight of salt
    구강 조성물.Oral composition.
  3. 제1항에 있어서,The method of claim 1,
    상기 천연물은 추출되거나, 발효추출되거나, 추출발효된The natural product is extracted, fermented or extracted and fermented
    구강 조성물.Oral composition.
  4. 제3항에 있어서,The method of claim 3,
    상기 추출은 물, 탄소수 1-4의 무수 또는 함수 저급 알코올, 탄소수 1-4의 저급 케톤, 탄소수 1-4의 저급 에스테르, 클로로포름 및 이들의 혼합물로 이루어진 군으로부터 선택된 하나 이상을 포함하는 용매에 의해 이루어지는The extraction is performed by a solvent comprising at least one selected from the group consisting of water, anhydrous or hydrous lower alcohols of 1-4 carbon atoms, lower ketones of 1-4 carbon atoms, lower esters of 1-4 carbon atoms, chloroform and mixtures thereof. Made up
    구강 조성물.Oral composition.
  5. 제1항에 있어서,The method of claim 1,
    상기 식물성 오일은 피마자 오일 및 님 오일을 포함하는The vegetable oil includes castor oil and nim oil
    구강 조성물.Oral composition.
  6. 제5항에 있어서,The method of claim 5,
    상기 피마자 오일 및 상기 님 오일의 중량비는 1:1 내지 5:1인The weight ratio of the castor oil and the nim oil is 1: 1 to 5: 1
    구강 조성물.Oral composition.
  7. 제1항에 있어서,The method of claim 1,
    상기 구강 조성물 100 중량부에 대하여, 상기 천연물 70 중량부 내지 90 중량부 및 상기 식물성 오일 10 중량부 내지 30 중량부를 함유하는 100 parts by weight of the oral composition, containing 70 parts by weight to 90 parts by weight of the natural product and 10 parts by weight to 30 parts by weight of the vegetable oil.
    구강 조성물.Oral composition.
  8. 제1항에 있어서,The method of claim 1,
    상기 구강 조성물은 스트렙토코커스 뮤탄스(Streptococcus mutans), 포르피로모나스 진지발리스(Porphyromonas Gingivalis) 및 스트렙토코커스 고도니(Streptococcus Gordonii)로 이루어진 군으로부터 선택된 하나 이상의 구강 세균을 억제하기 위한 것인The oral composition is for inhibiting one or more oral bacteria selected from the group consisting of Streptococcus mutans, Porphyromonas Gingivalis and Streptococcus Gordonii.
    구강 조성물.Oral composition.
  9. 제1항에 있어서,The method of claim 1,
    상기 구강 조성물은 산제, 과립제, 정제, 캡슐제, 크림제, 투명겔제 또는 반투명겔제의 형태로 제형된 것인The oral composition is formulated in the form of a powder, granules, tablets, capsules, creams, transparent gels or translucent gels
    구강 조성물. Oral composition.
  10. (a) 괄루인, 대회향, 차전자, 토복령, 산수유 및 소금을 포함하는 천연물을 추출하여 추출물, 발효추출물 또는 추출발효물을 제조하는 단계; 및(a) extracting a natural product including a parenthesis, gyunhyang fragrance, cha-cha, bokbokyeong, cornus and salt to prepare an extract, fermented extract or extract fermentation; And
    (b) 상기 추출물, 발효추출물 또는 추출발효물에 식물성 오일을 첨가하고 혼합하는 단계를 포함하는 (b) adding and mixing vegetable oils to the extract, fermented extract or fermented extract;
    구강 조성물의 제조방법. Method for preparing the oral composition.
  11. 제10항에 있어서,The method of claim 10,
    상기 (a) 단계에서 추출은 80℃ 내지 90℃에서 60분 내지 70분 동안 수행되는 Extraction in the step (a) is carried out for 60 to 70 minutes at 80 ℃ to 90 ℃
    구강 조성물의 제조방법.Method for preparing the oral composition.
  12. 제10항에 있어서,The method of claim 10,
    상기 (b) 단계에서 식물성 오일은 피마자 오일 및 님 오일을 포함하는In the step (b) the vegetable oil comprises castor oil and nim oil
    구강 조성물의 제조방법.Method for preparing the oral composition.
PCT/KR2016/012858 2015-11-18 2016-11-09 Oral composition and method for preparing same WO2017086653A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2015-0161974 2015-11-18
KR1020150161974A KR101664810B1 (en) 2015-11-18 2015-11-18 Oral composition and manufacturing method thereof

Publications (1)

Publication Number Publication Date
WO2017086653A1 true WO2017086653A1 (en) 2017-05-26

Family

ID=57173578

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/012858 WO2017086653A1 (en) 2015-11-18 2016-11-09 Oral composition and method for preparing same

Country Status (2)

Country Link
KR (1) KR101664810B1 (en)
WO (1) WO2017086653A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106214542A (en) * 2016-08-19 2016-12-14 浙江师范大学 Fructus Trichosanthis natural plant toothpaste
KR102269164B1 (en) * 2019-01-15 2021-12-13 동신대학교산학협력단 Composition for improvement of dental caries and periodontal disease using an extract of seeds of Phaseolus radiatus, etc.
KR102563528B1 (en) * 2021-02-23 2023-08-08 (주)코아바이오텍 Solution composition for liquid based cytology of cervical cancer

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030047613A (en) * 2001-12-11 2003-06-18 오세군 Composition of toothpaste containing antiseptic Neem extracts
KR20040066313A (en) * 2003-01-17 2004-07-27 주식회사 엘지생활건강 Tooth whitening composition using oriental drug
KR20060054780A (en) * 2004-11-16 2006-05-23 강영욱 Material improving sanitation of oral cavity
KR100812968B1 (en) * 2006-12-11 2008-03-11 조진원 A study of purifying hunman inner body with natural herbal plants
KR20100094112A (en) * 2009-02-18 2010-08-26 충청대학 산학협력단 Functional toothpaste including date

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030047613A (en) * 2001-12-11 2003-06-18 오세군 Composition of toothpaste containing antiseptic Neem extracts
KR20040066313A (en) * 2003-01-17 2004-07-27 주식회사 엘지생활건강 Tooth whitening composition using oriental drug
KR20060054780A (en) * 2004-11-16 2006-05-23 강영욱 Material improving sanitation of oral cavity
KR100812968B1 (en) * 2006-12-11 2008-03-11 조진원 A study of purifying hunman inner body with natural herbal plants
KR20100094112A (en) * 2009-02-18 2010-08-26 충청대학 산학협력단 Functional toothpaste including date

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"What's the Oil-pulling?", WEBSITE: JIKIMI BLOG, 17 June 2015 (2015-06-17), pages 1 - 5, Retrieved from the Internet <URL:http://blog.naver.com/ydbotanics/220392921437> *

Also Published As

Publication number Publication date
KR101664810B1 (en) 2016-10-12

Similar Documents

Publication Publication Date Title
US6811769B2 (en) Oral composition, method of making the oral composition and oral hygiene method in japanese and chinese herbal remedy
KR101354923B1 (en) Oral hygiene composition using an extract of curcuma longa and an extract eriobotrya japonica
SE461378B (en) COMPOSITION FOR MEDICAL TREATMENT AND PREVENTION TO PREVENT PARADONTOPATHY
WO2018151567A1 (en) Toothpaste composition comprising jade component
CN108464963A (en) It is a kind of for the composition in oral cavity and its application and preparation method
WO2017086653A1 (en) Oral composition and method for preparing same
WO2017007140A1 (en) Oral composition for preventing and treating periodontitis, comprising mulberry root bark extract and winged spindle extract as active ingredients
KR102408893B1 (en) Composition for prevention or treatment of oral disease comprising Pueraria Extract
WO2016010284A1 (en) Toothpaste composition containing curcuma longa l., and preparation method therefor
KR101202302B1 (en) Composition for treating and preventing periodontal disease and caries comprising bee venom
WO2016186335A2 (en) Oral composition for cavity prevention and treatment including mulberry root extract and euonymus alatus extract as effective ingredients
KR102636026B1 (en) Composition for prevention or trreatment of dental disease comprising an extract of Thalictrum aquilegiifolium
JP3008525B2 (en) Oral composition
KR20170103476A (en) Composition for prevention or treatment of oral disease comprising ROSAE LAEVIGATAE Extract
CN107397805B (en) Improve oral hygiene, prevention and the composition and preparation method for the treatment of mouth disease
CN113197830B (en) Toothpaste and preparation method thereof
CN104324062A (en) American ginseng conversion saponin, traditional Chinese medicine mouth care composition thereof and preparation method and application
WO2010120005A1 (en) Method for extracting antibiotic materials from licorice and licorice extracts obtained by the method for cavity prevention
JP2012067065A (en) Anti-periodontic disease medicine
KR102415612B1 (en) Composition for prevention or treatment of oral disease comprising Melonis Pedicellus Extract
KR20020082308A (en) Composition for the mouth containing extraction of Euonymus alatus Sieb
KR0149483B1 (en) Antiplague compositions
WO2023210880A1 (en) Composition comprising ginsenoside compound k or complex ginsenoside composition for preventing or treating periodontal disease
KR20170125752A (en) Oral composition
KR101932681B1 (en) Composition for inhibiting halitosis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16866605

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16866605

Country of ref document: EP

Kind code of ref document: A1